BR112015000106B1 - Moduladores heterocíclicos de síntese de lipídio, composição farmacêutica e uso dos referidos moduladores - Google Patents
Moduladores heterocíclicos de síntese de lipídio, composição farmacêutica e uso dos referidos moduladores Download PDFInfo
- Publication number
- BR112015000106B1 BR112015000106B1 BR112015000106-8A BR112015000106A BR112015000106B1 BR 112015000106 B1 BR112015000106 B1 BR 112015000106B1 BR 112015000106 A BR112015000106 A BR 112015000106A BR 112015000106 B1 BR112015000106 B1 BR 112015000106B1
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- compound
- halogen
- mmol
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Reproductive Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261667894P | 2012-07-03 | 2012-07-03 | |
US61/667,894 | 2012-07-03 | ||
US201261698511P | 2012-09-07 | 2012-09-07 | |
US61/698,511 | 2012-09-07 | ||
US201261699819P | 2012-09-11 | 2012-09-11 | |
US61/699,819 | 2012-09-11 | ||
US201361785933P | 2013-03-14 | 2013-03-14 | |
US61/785,933 | 2013-03-14 | ||
PCT/US2013/048950 WO2014008197A1 (fr) | 2012-07-03 | 2013-07-01 | Modulateurs hétérocycliques de la synthèse des lipides |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112015000106A2 BR112015000106A2 (pt) | 2017-06-27 |
BR112015000106B1 true BR112015000106B1 (pt) | 2022-02-22 |
Family
ID=48790663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015000106-8A BR112015000106B1 (pt) | 2012-07-03 | 2013-07-01 | Moduladores heterocíclicos de síntese de lipídio, composição farmacêutica e uso dos referidos moduladores |
Country Status (18)
Country | Link |
---|---|
US (3) | US9428502B2 (fr) |
EP (1) | EP2870150B1 (fr) |
JP (1) | JP6109934B2 (fr) |
KR (1) | KR102071095B1 (fr) |
CN (1) | CN104507928B (fr) |
AU (2) | AU2013286894B2 (fr) |
BR (1) | BR112015000106B1 (fr) |
CA (1) | CA2877999C (fr) |
ES (1) | ES2738823T3 (fr) |
HK (1) | HK1208445A1 (fr) |
IL (1) | IL236407A (fr) |
IN (1) | IN2015DN00137A (fr) |
MX (1) | MX364815B (fr) |
NZ (2) | NZ729443A (fr) |
PL (1) | PL2870150T3 (fr) |
SG (1) | SG11201500024YA (fr) |
WO (1) | WO2014008197A1 (fr) |
ZA (1) | ZA201409477B (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170119786A1 (en) | 2011-03-08 | 2017-05-04 | 3-V Biosciences, Inc. | Heterocyclic modulators of lipid synthesis |
US9624173B2 (en) * | 2011-03-08 | 2017-04-18 | 3-V Biosciences, Inc. | Heterocyclic modulators of lipid synthesis |
US8871790B2 (en) * | 2011-03-08 | 2014-10-28 | 3-V Biosciences, Inc. | Heterocyclic modulators of lipid synthesis |
JP6109934B2 (ja) | 2012-07-03 | 2017-04-05 | 3−ブイ・バイオサイエンシーズ・インコーポレイテッド3−V Biosciences,Inc. | 脂質合成の複素環モジュレーター |
JP6820097B2 (ja) * | 2013-12-20 | 2021-01-27 | サギメット バイオサイエンシーズ インコーポレイテッド | 脂質合成の複素環式モジュレータ及びその組み合わせ |
RU2766087C2 (ru) * | 2014-01-07 | 2022-02-07 | Сагимет Байосайенсиз Инк. | Гетероциклические модуляторы синтеза липидов для применения против рака и вирусных инфекций |
ES2833454T3 (es) * | 2014-08-15 | 2021-06-15 | Sagimet Biosciences Inc | Inhibidor de la ácido graso sintasa para su uso en el tratamiento de un cáncer farmacorresistente |
EP3183248B1 (fr) * | 2014-08-21 | 2020-11-11 | Bristol-Myers Squibb Company | Dérivés rattachés de benzamide utilisés comme puissants inhibiteurs de rock |
WO2016087489A1 (fr) | 2014-12-03 | 2016-06-09 | Janssen Pharmaceutica Nv | Ligands radiomarqués des récepteurs mglur2 utilisés en tep |
CN107428728A (zh) * | 2015-03-19 | 2017-12-01 | 3-V生物科学股份有限公司 | 脂质合成的杂环调节剂 |
JP2018083758A (ja) * | 2015-03-25 | 2018-05-31 | 旭硝子株式会社 | ピラゾール誘導体の製造方法 |
JP6999424B2 (ja) | 2015-06-18 | 2022-01-18 | エイティナイン バイオ リミテッド | 1,4-置換ピペリジン誘導体 |
EP3310773B1 (fr) | 2015-06-18 | 2020-12-02 | 89Bio Ltd. | Dérivés de 4-benzyl et 4-benzoyl-pipéridine substitués |
WO2017103182A1 (fr) | 2015-12-18 | 2017-06-22 | Janssen Pharmaceutica Nv | Ligands des récepteurs mglur2/3 radiomarqués utilisés en tep |
AU2016374568B2 (en) | 2015-12-18 | 2020-08-27 | Janssen Pharmaceutica Nv | Radiolabelled mGluR2/3 PET ligands |
JP2019501222A (ja) | 2016-01-07 | 2019-01-17 | シーエス ファーマテック リミテッド | Egfrチロシンキナーゼの臨床的に重要な変異体の選択的阻害薬 |
WO2017119732A1 (fr) | 2016-01-08 | 2017-07-13 | Samsung Electronics Co., Ltd. | Dispositif électronique, et son procédé de fonctionnement |
EP3426772A4 (fr) | 2016-03-09 | 2019-08-28 | Beijing Percans Oncology Co. Ltd. | Cultures en suspension de cellules tumorales et procédés associés |
CA3043308A1 (fr) * | 2016-11-11 | 2018-05-17 | 3-V Biosciences, Inc. | Modulateurs heterocycliques de synthese de lipides |
CN107954852A (zh) * | 2017-11-30 | 2018-04-24 | 贝利化学(张家港)有限公司 | 2,5-二卤代苯甲酸的制备方法 |
CN111592495A (zh) * | 2020-07-06 | 2020-08-28 | 上海启讯医药科技有限公司 | 一种2-正丁基-4-氯-5甲酰基咪唑的制备方法 |
CN114988975A (zh) * | 2022-06-28 | 2022-09-02 | 江苏科技大学 | 一种基于有机染料催化的β-三氟甲基烯胺化合物的制备方法 |
CN116482278B (zh) * | 2023-05-06 | 2024-02-09 | 广州清瑞生物科技有限责任公司 | 一种用于检测阿昔洛韦的对照品的制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602006011363D1 (de) | 2005-12-01 | 2010-02-04 | Hoffmann La Roche | Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer |
WO2008030891A2 (fr) | 2006-09-05 | 2008-03-13 | Bipar Sciences, Inc. | Inhibition de la synthèse d'acides gras au moyen d'inhibiteurs parp et méthodes de traitement associées |
WO2008059214A1 (fr) * | 2006-11-13 | 2008-05-22 | Astrazeneca Ab | Dérivés de bisamide et utilisation de ceux-ci en tant qu'inhibiteurs de l'acide gras synthase |
TW200833663A (en) * | 2006-12-21 | 2008-08-16 | Astrazeneca Ab | Therapeutic agents |
TW200831092A (en) * | 2006-12-21 | 2008-08-01 | Astrazeneca Ab | Therapeutic agents |
WO2008075077A1 (fr) * | 2006-12-21 | 2008-06-26 | Astrazeneca Ab | Dérivés de pipéridine destinés au traitement de l'obésité |
ES2883274T3 (es) | 2011-03-08 | 2021-12-07 | Sagimet Biosciences Inc | Moduladores heterocíclicos de la síntesis de lípidos |
US9624173B2 (en) * | 2011-03-08 | 2017-04-18 | 3-V Biosciences, Inc. | Heterocyclic modulators of lipid synthesis |
US8871790B2 (en) * | 2011-03-08 | 2014-10-28 | 3-V Biosciences, Inc. | Heterocyclic modulators of lipid synthesis |
US20170119786A1 (en) * | 2011-03-08 | 2017-05-04 | 3-V Biosciences, Inc. | Heterocyclic modulators of lipid synthesis |
JP6109934B2 (ja) | 2012-07-03 | 2017-04-05 | 3−ブイ・バイオサイエンシーズ・インコーポレイテッド3−V Biosciences,Inc. | 脂質合成の複素環モジュレーター |
JP6820097B2 (ja) * | 2013-12-20 | 2021-01-27 | サギメット バイオサイエンシーズ インコーポレイテッド | 脂質合成の複素環式モジュレータ及びその組み合わせ |
RU2766087C2 (ru) * | 2014-01-07 | 2022-02-07 | Сагимет Байосайенсиз Инк. | Гетероциклические модуляторы синтеза липидов для применения против рака и вирусных инфекций |
ES2833454T3 (es) * | 2014-08-15 | 2021-06-15 | Sagimet Biosciences Inc | Inhibidor de la ácido graso sintasa para su uso en el tratamiento de un cáncer farmacorresistente |
CN107428728A (zh) * | 2015-03-19 | 2017-12-01 | 3-V生物科学股份有限公司 | 脂质合成的杂环调节剂 |
-
2013
- 2013-07-01 JP JP2015520627A patent/JP6109934B2/ja active Active
- 2013-07-01 IN IN137DEN2015 patent/IN2015DN00137A/en unknown
- 2013-07-01 PL PL13737098T patent/PL2870150T3/pl unknown
- 2013-07-01 AU AU2013286894A patent/AU2013286894B2/en active Active
- 2013-07-01 NZ NZ729443A patent/NZ729443A/en unknown
- 2013-07-01 KR KR1020157002727A patent/KR102071095B1/ko active IP Right Grant
- 2013-07-01 CN CN201380035602.4A patent/CN104507928B/zh active Active
- 2013-07-01 WO PCT/US2013/048950 patent/WO2014008197A1/fr active Application Filing
- 2013-07-01 MX MX2015000151A patent/MX364815B/es active IP Right Grant
- 2013-07-01 EP EP13737098.7A patent/EP2870150B1/fr active Active
- 2013-07-01 SG SG11201500024YA patent/SG11201500024YA/en unknown
- 2013-07-01 BR BR112015000106-8A patent/BR112015000106B1/pt active IP Right Grant
- 2013-07-01 CA CA2877999A patent/CA2877999C/fr active Active
- 2013-07-01 ES ES13737098T patent/ES2738823T3/es active Active
- 2013-07-01 NZ NZ703162A patent/NZ703162A/en active IP Right Revival
-
2014
- 2014-12-22 ZA ZA2014/09477A patent/ZA201409477B/en unknown
- 2014-12-23 IL IL236407A patent/IL236407A/en active IP Right Grant
- 2014-12-31 US US14/587,908 patent/US9428502B2/en active Active
-
2015
- 2015-09-15 HK HK15109016.4A patent/HK1208445A1/xx unknown
-
2016
- 2016-07-05 US US15/201,824 patent/US10053450B2/en active Active
-
2017
- 2017-11-21 AU AU2017265027A patent/AU2017265027A1/en not_active Abandoned
-
2018
- 2018-03-30 US US15/941,387 patent/US10118913B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10118913B2 (en) | Heterocyclic modulators of lipid synthesis | |
EP3083583B1 (fr) | Modulateurs hétérocycliques de la synthèse des lipides et combinaisons en contenant | |
AU2017260125B2 (en) | Aromatic sulfonamide derivatives | |
KR102317169B1 (ko) | 2-(모르폴린-4-일)-1,7-나프티리딘 | |
CN109843873B (zh) | 炔代杂环化合物、其制备方法及其在医药学上的应用 | |
JP2022189853A (ja) | menin-MLL相互作用の阻害剤 | |
JP5970003B2 (ja) | アミノピラジン化合物 | |
BR112019021790A2 (pt) | compostos bicíclicos e métodos de uso | |
KR20150108389A (ko) | 치환된 피롤로피리미딘 화합물, 이의 조성물 및 이에 의한 치료 방법 | |
WO2018104305A1 (fr) | Sulfamoylbenzamides | |
BR112021010427A2 (pt) | compostos derivados de amino triazolo quinazolina substituídos na posição 9 como antagonistas de receptores de adenosina, suas composições farmacêuticas e seus usos | |
EP4217358A1 (fr) | Indazoles en tant qu'inhibiteurs de kinase 1 progénitrice hématopoïétique (hpk1) et leurs procédés d'utilisation | |
TW202400607A (zh) | 環狀化合物、製備方法及其醫藥用途 | |
JP2010540422A (ja) | チエノピリミジン化合物類 | |
RU2779069C2 (ru) | Гетероциклические модуляторы синтеза липидов | |
EA040608B1 (ru) | Ароматические сульфонамидные производные |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: SAGIMET BIOSCIENCES INC. (US) |
|
B25G | Requested change of headquarter approved |
Owner name: SAGIMET BIOSCIENCES INC. (US) |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/07/2013, OBSERVADAS AS CONDICOES LEGAIS. |